OREX

Orexigen Therapeutics, Inc. News Headlines

$4.39
*  
0.18
4.28%
Get OREX Alerts
*Delayed - data as of Jul. 28, 2015  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Orexigen: Contrave Sales Pop, Equity Response Muted
4/24/2015 7:39:00 PM - Seeking Alpha


Arena: Belviq Scripts Pop, Recover From Previous Dip
4/24/2015 7:26:00 PM - Seeking Alpha






Orexigen Investors Can Get Litigation Insight From Vivus
4/24/2015 8:29:00 AM - Seeking Alpha










Orexigen Faces Generic Challenge For Anti-Obesity Drug
4/22/2015 12:24:00 PM - Seeking Alpha




Should Orexigen Fear This Upstart?
4/20/2015 9:45:00 AM - Investopedia


Don't Write Off Arena As Yet
4/15/2015 8:33:00 AM - Seeking Alpha




Vivus Sales Remain Flat - Stock Trend Not Good
4/13/2015 1:19:00 PM - Seeking Alpha


Arena's 15,000 Scripts Set Pace Vs. Competitors
4/13/2015 11:00:00 AM - Seeking Alpha








Novo Nordisk Quietly Becoming Big Player In Obesity Space
4/9/2015 11:45:00 AM - Seeking Alpha










Novo Nordisk Entry Is Bullish For The Anti-Obesity Space
4/2/2015 9:20:00 PM - Seeking Alpha